P
Peter Lidbrink
Researcher at Karolinska Institutet
Publications - 48
Citations - 3635
Peter Lidbrink is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Mycoplasma genitalium & Chlamydia trachomatis. The author has an hindex of 28, co-authored 48 publications receiving 3548 citations. Previous affiliations of Peter Lidbrink include Astra & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.
Journal ArticleDOI
Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic.
TL;DR: A quantitative 5′ nuclease assay (TaqMan PCR) was developed and validated and consistently detected <5 genome copies without cross-reactions with other mycoplasmas.
Journal ArticleDOI
Minor tranquillizers, stress and central catecholamine neurons.
TL;DR: It seems that the decrease in nervous activity in DA and NA neurons produced by chlordiazepoxide and diazepam may be responsible for part of the pharmacological effects of these tranquillizers such as sedation and EEG slowing.
Journal ArticleDOI
The origin of the dopamine nerve terminals in limbic and frontal cortex. Evidence for meso-cortico dopamine neurons
Journal ArticleDOI
The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons.
TL;DR: The present results support the view that tertiary amines of the imipramine-type of drugs, which are well-known and frequently used antidepressant drugs, preferentially block 5-HT uptake in the central 5- HT neurons, whereas secondary amine types, such as desipramsine, preferentialially block NA uptake inThe central NA neurons.